|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2009-3-23
|
|
pubmed:abstractText |
Carboplatin plays an important role in the conservative management of retinoblastoma, but is associated with risk of ototoxicity in these young children whose sensory prognosis may be also compromised by their loss of vision. This retrospective study analyzed the impact of carboplatin on hearing in the context of conservative management of children with retinoblastoma.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1545-5017
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
(c) 2009 Wiley-Liss, Inc.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
52
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
637-43
|
|
pubmed:dateRevised |
2009-7-20
|
|
pubmed:meshHeading |
pubmed-meshheading:19148943-Antineoplastic Agents,
pubmed-meshheading:19148943-Carboplatin,
pubmed-meshheading:19148943-Child, Preschool,
pubmed-meshheading:19148943-Ear Diseases,
pubmed-meshheading:19148943-Female,
pubmed-meshheading:19148943-Follow-Up Studies,
pubmed-meshheading:19148943-Humans,
pubmed-meshheading:19148943-Infant,
pubmed-meshheading:19148943-Infant, Newborn,
pubmed-meshheading:19148943-Male,
pubmed-meshheading:19148943-Retinoblastoma,
pubmed-meshheading:19148943-Treatment Outcome
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Analysis of ototoxicity in young children receiving carboplatin in the context of conservative management of unilateral or bilateral retinoblastoma.
|
|
pubmed:affiliation |
Department of Pediatric Oncology, Institut Curie, Paris, France.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
